Case series of selective anti-tumor necrosis factor alpha therapy using infliximab in patients with nonresponsive chronic HLA-B27-associated anterior uveitis: comment on the articles by Brandt et al

Arthritis Rheum. 2002 Oct;46(10):2821-2; author reply 2822-4. doi: 10.1002/art.10469.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Female
  • HLA-B27 Antigen / genetics*
  • Humans
  • Infliximab
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Uveitis, Anterior / drug therapy*
  • Uveitis, Anterior / genetics

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • HLA-B27 Antigen
  • Tumor Necrosis Factor-alpha
  • Infliximab